MLSS Milestone Scientific Inc
Price (delayed)
$0.95
Market cap
$74.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.06
Enterprise value
$71.55M
Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary
Highlights
Milestone Scientific's EPS has increased by 40% YoY and by 14% from the previous quarter
The company's gross margin rose by 8% YoY and by 2.9% QoQ
The net income has grown by 32% year-on-year but it has declined by 2.1% since the previous quarter
The debt has grown by 12% from the previous quarter but it has contracted by 12% YoY
The company's quick ratio has shrunk by 51% YoY and by 30% QoQ
The equity has contracted by 27% YoY and by 19% from the previous quarter
Key stats
What are the main financial stats of MLSS
Market
Valuations
Earnings
Shares outstanding
78.38M
Market cap
$74.46M
Enterprise value
$71.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
12.69
Price to sales (P/S)
8.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.29
Revenue
$8.63M
Gross profit
$6.43M
Operating income
-$6.76M
Net income
-$4.71M
EBIT
-$4.71M
EBITDA
-$4.58M
Free cash flow
-$2.93M
Per share
Balance sheet
Liquidity
EPS
-$0.06
EPS diluted
-$0.06
Free cash flow per share
-$0.04
Book value per share
$0.07
Revenue per share
$0.11
TBVPS
$0.12
Total assets
$9.8M
Total liabilities
$3.96M
Debt
$349,054
Equity
$5.83M
Working capital
$5.54M
Debt to equity
0.06
Current ratio
2.48
Quick ratio
1
Net debt/EBITDA
0.64
Margins
Efficiency
Dividend
EBITDA margin
-53.1%
Gross margin
74.6%
Net margin
-54.6%
Operating margin
-78.3%
Return on assets
-42.5%
Return on equity
-66.2%
Return on invested capital
-153.2%
Return on capital employed
-77.9%
Return on sales
-54.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MLSS stock price
How has the Milestone Scientific stock price performed over time
Intraday
2.7%
1 week
5.26%
1 month
-5.94%
1 year
69.95%
YTD
-1.04%
QTD
1.87%
Financial performance
How have Milestone Scientific's revenue and profit performed over time
Revenue
$8.63M
Gross profit
$6.43M
Operating income
-$6.76M
Net income
-$4.71M
Gross margin
74.6%
Net margin
-54.6%
The net income has grown by 32% year-on-year but it has declined by 2.1% since the previous quarter
The net margin has grown by 23% YoY but it has contracted by 5% from the previous quarter
The revenue is down by 12% year-on-year and by 2.8% since the previous quarter
The company's gross margin rose by 8% YoY and by 2.9% QoQ
Growth
What is Milestone Scientific's growth rate over time
Valuation
What is Milestone Scientific stock price valuation
P/E
N/A
P/B
12.69
P/S
8.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.29
Milestone Scientific's EPS has increased by 40% YoY and by 14% from the previous quarter
The P/B is 69% higher than the 5-year quarterly average of 7.5 and 43% higher than the last 4 quarters average of 8.9
The equity has contracted by 27% YoY and by 19% from the previous quarter
The P/S is 26% less than the 5-year quarterly average of 11.8 but 22% more than the last 4 quarters average of 7.2
The revenue is down by 12% year-on-year and by 2.8% since the previous quarter
Efficiency
How efficient is Milestone Scientific business performance
MLSS's ROA is up by 30% YoY but it is down by 6% QoQ
The company's return on invested capital fell by 28% YoY and by 23% QoQ
Milestone Scientific's ROS has increased by 23% YoY but it has decreased by 4.6% from the previous quarter
The return on equity has increased by 22% year-on-year but it has declined by 10% since the previous quarter
Dividends
What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MLSS.
Financial health
How did Milestone Scientific financials performed over time
The total assets is 147% greater than the total liabilities
The company's quick ratio has shrunk by 51% YoY and by 30% QoQ
Milestone Scientific's current ratio has decreased by 29% YoY and by 13% from the previous quarter
The debt is 94% less than the equity
Milestone Scientific's debt to equity has soared by 50% from the previous quarter and by 20% YoY
The equity has contracted by 27% YoY and by 19% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.